{
  "title": "Cel-Sci Corporation",
  "content-preview": "Cel-Sci Corporation (NYSE American: CVM), is a biotechnology company that tests drugs for the treatment of cancer, autoimmune and infectious diseases through the research and development of immunotherapy products.\nCel-Sci's main product is the drug Multikine, an immunotherapeutic agent designed to f",
  "url": "https://en.wikipedia.org/wiki/Cel-Sci_Corporation",
  "pageid": 63280117,
  "title-terms": {
    "celsci": 1,
    "corporation": 1
  },
  "content-terms": {
    "celsci": 11,
    "corporation": 2,
    "nyse": 1,
    "american": 1,
    "cvm": 1,
    "biotechnology": 1,
    "company": 12,
    "tests": 1,
    "drugs": 1,
    "treatment": 2,
    "cancer": 5,
    "autoimmune": 1,
    "infectious": 1,
    "diseases": 1,
    "research": 4,
    "development": 3,
    "immunotherapy": 1,
    "products": 2,
    "celscis": 4,
    "main": 1,
    "product": 1,
    "drug": 5,
    "multikine": 7,
    "immunotherapeutic": 1,
    "agent": 1,
    "designed": 1,
    "fight": 1,
    "stimulating": 1,
    "bodys": 1,
    "immune": 2,
    "system": 4,
    "currently": 1,
    "phase": 5,
    "iii": 3,
    "clinical": 3,
    "trials": 1,
    "food": 1,
    "administration": 1,
    "fda": 6,
    "also": 4,
    "referred": 1,
    "leukocyte": 1,
    "interleukin": 1,
    "injection": 1,
    "li": 1,
    "ii": 1,
    "testing": 3,
    "patients": 4,
    "head": 4,
    "neck": 4,
    "early": 1,
    "2000s": 1,
    "demonstrated": 1,
    "tumorreducing": 1,
    "ability": 1,
    "january": 1,
    "2007": 1,
    "us": 2,
    "cleared": 1,
    "3": 3,
    "trial": 3,
    "designated": 1,
    "orphan": 1,
    "neoadjuvant": 1,
    "therapy": 1,
    "squamous": 1,
    "cell": 1,
    "carcinoma": 1,
    "total": 1,
    "928": 1,
    "enrolled": 1,
    "time": 1,
    "subsequently": 1,
    "june": 3,
    "2021": 2,
    "announced": 2,
    "study": 5,
    "missed": 3,
    "primary": 2,
    "endpoint": 3,
    "history": 1,
    "founded": 1,
    "1983": 1,
    "germany": 1,
    "maximilian": 2,
    "de": 4,
    "clara": 3,
    "switzerland": 1,
    "president": 1,
    "resignation": 1,
    "2016": 1,
    "geert": 2,
    "kersten": 3,
    "claras": 1,
    "stepson": 1,
    "companys": 4,
    "ceo": 2,
    "since": 1,
    "1995": 1,
    "went": 1,
    "public": 2,
    "year": 1,
    "founding": 1,
    "investment": 1,
    "firm": 2,
    "took": 1,
    "later": 2,
    "folded": 1,
    "united": 1,
    "states": 1,
    "operations": 1,
    "based": 1,
    "baltimore": 1,
    "maryland": 1,
    "mid1990s": 1,
    "may": 1,
    "1992": 1,
    "securities": 2,
    "exchange": 1,
    "commission": 1,
    "issued": 2,
    "cease": 1,
    "desist": 1,
    "order": 2,
    "thenpresident": 1,
    "stated": 1,
    "august": 2,
    "1988": 1,
    "1991": 1,
    "2\u201331": 1,
    "weeks": 1,
    "late": 1,
    "file": 1,
    "16": 1,
    "forms": 1,
    "documenting": 1,
    "sales": 1,
    "26": 2,
    "million": 3,
    "stock": 5,
    "confirmed": 1,
    "paid": 2,
    "analyst": 2,
    "brokerage": 1,
    "honolulu": 1,
    "inc": 1,
    "write": 1,
    "report": 1,
    "though": 2,
    "claimed": 1,
    "affect": 1,
    "conclusion": 1,
    "undervalued": 1,
    "1997": 1,
    "bought": 1,
    "technology": 1,
    "enabled": 1,
    "regulation": 1,
    "responses": 1,
    "licensing": 1,
    "dutch": 1,
    "sittona": 1,
    "mysterious": 1,
    "cash": 2,
    "offer": 2,
    "new": 1,
    "york": 1,
    "times": 2,
    "reported": 2,
    "1999": 1,
    "received": 1,
    "unsolicited": 1,
    "124": 1,
    "unidentified": 1,
    "person": 1,
    "argentina": 1,
    "arbitration": 2,
    "victory": 1,
    "2018": 1,
    "45yearlong": 1,
    "suit": 1,
    "filed": 1,
    "october": 1,
    "2013": 1,
    "cro": 2,
    "inventiv": 1,
    "health": 1,
    "breach": 1,
    "contract": 1,
    "arbitrator": 1,
    "awarded": 1,
    "29": 1,
    "damages": 1,
    "failed": 1,
    "enroll": 1,
    "required": 1,
    "number": 1,
    "period": 1,
    "2": 1,
    "years": 1,
    "thus": 1,
    "delaying": 1,
    "lifted": 1,
    "hold": 1,
    "imposed": 1,
    "2017": 1,
    "allowed": 1,
    "advance": 1,
    "2020": 2,
    "trading": 3,
    "halt": 2,
    "february": 1,
    "dropped": 1,
    "424": 1,
    "news": 1,
    "pending": 1,
    "released": 1,
    "letter": 1,
    "shareholders": 1,
    "concerning": 1,
    "stage": 1,
    "results": 1,
    "28": 1,
    "higher": 1,
    "risk": 2,
    "subgroup": 2,
    "achieve": 1,
    "10": 1,
    "improvement": 1,
    "overall": 1,
    "survival": 1,
    "even": 1,
    "lower": 1,
    "declared": 1,
    "would": 1,
    "apply": 1,
    "approval": 1,
    "despite": 1,
    "studys": 1,
    "following": 1,
    "announcement": 1,
    "lost": 1,
    "4050": 1,
    "value": 1,
    "one": 1,
    "day": 1,
    "halted": 1,
    "least": 1,
    "worked": 1,
    "leaps": 1,
    "ligand": 1,
    "epitope": 1,
    "antigen": 1,
    "presentation": 1,
    "therapeutic": 1,
    "vaccines": 1,
    "rheumatoid": 1,
    "arthritis": 1,
    "hgp30": 1,
    "determine": 1,
    "effective": 1,
    "aids": 1,
    "virus": 1,
    "1996": 1,
    "washington": 1,
    "post": 1,
    "conducting": 1,
    "without": 1,
    "backing": 1,
    "couldnt": 1,
    "agree": 1,
    "details": 1,
    "said": 1,
    "regulatory": 1,
    "organization": 1,
    "analysts": 1,
    "quoted": 1,
    "stating": 1,
    "decision": 1,
    "could": 1,
    "cause": 1,
    "delays": 1,
    "event": 1,
    "redo": 1,
    "meet": 1,
    "standards": 1,
    "references": 1
  },
  "title-length": 2,
  "content-length": 424,
  "curious_frequency": 4,
  "uplifting_frequency": 1,
  "entertaining_frequency": 0,
  "sad_frequency": 2,
  "general_frequency": 0
}